Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gugliotta

Showing results (391-400 of 469) with videos related to

Pageof 47
Sort By:
British Journal of Haematology|October 4, 2007
Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptidesAntonio Curti, Patrizia Tosi, Patrizia Comoli, et al.
Oncotarget|May 19, 2018
Differential proteomic profile of leukemic CD34+ progenitor cells from chronic myeloid leukemia patientsMaria Rosaria Ricciardi, Valentina Salvestrini, Roberto Licchetta, et al.
Applied Microbiology and Biotechnology|May 1, 2023
Design and characterization of chimeric Rabies-SARS-CoV-2 virus-like particles for vaccine purposesErnesto Garay, Diego Fontana, Javier Villarraza, et al.
Leukemia|January 26, 2007
A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working groupG Barosi, C Besses, G Birgegard, et al.
The Oncologist|June 10, 2025
Ultrasound-guided core needle biopsy of nodular lesions of the spleen in hematology clinical practiceAlessandro Broccoli, Sofia Maria Bakken, Lisa Argnani, et al.
Applied Microbiology and Biotechnology|April 24, 2023
A COVID-19 vaccine candidate based on SARS-CoV-2 spike protein and immune-stimulating complexesJavier Villarraza, Antonela Fuselli, Agustina Gugliotta, et al.
European Journal of Haematology|September 19, 2024
Efficacy and Safety of Frontline Single-Agent Rituximab in Extranodal Marginal Zone LymphomaCamilla Mazzoni, Lisa Argnani, Beatrice Casadei, et al.
Blood|November 2, 2006
Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experienceMaria Gabriella Mazzucconi, Paola Fazi, Sayla Bernasconi, et al.
The Journal of Pathology|August 12, 2009
Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray-based CGH analysisCaterina Marchiò, Maryou B Lambros, Patrizia Gugliotta, et al.
Human Pathology|July 26, 2015
Immunohistochemical and molecular profiling of histologically defined apocrine carcinomas of the breastSemir Vranic, Caterina Marchiò, Isabella Castellano, et al.
Pageof 47

Showing results (391-400 of 469) with videos related to

Sort By:
Pageof 47
British Journal of Haematology|October 4, 2007
Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptidesAntonio Curti, Patrizia Tosi, Patrizia Comoli, et al.
Oncotarget|May 19, 2018
Differential proteomic profile of leukemic CD34+ progenitor cells from chronic myeloid leukemia patientsMaria Rosaria Ricciardi, Valentina Salvestrini, Roberto Licchetta, et al.
Applied Microbiology and Biotechnology|May 1, 2023
Design and characterization of chimeric Rabies-SARS-CoV-2 virus-like particles for vaccine purposesErnesto Garay, Diego Fontana, Javier Villarraza, et al.
Leukemia|January 26, 2007
A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working groupG Barosi, C Besses, G Birgegard, et al.
The Oncologist|June 10, 2025
Ultrasound-guided core needle biopsy of nodular lesions of the spleen in hematology clinical practiceAlessandro Broccoli, Sofia Maria Bakken, Lisa Argnani, et al.
Applied Microbiology and Biotechnology|April 24, 2023
A COVID-19 vaccine candidate based on SARS-CoV-2 spike protein and immune-stimulating complexesJavier Villarraza, Antonela Fuselli, Agustina Gugliotta, et al.
European Journal of Haematology|September 19, 2024
Efficacy and Safety of Frontline Single-Agent Rituximab in Extranodal Marginal Zone LymphomaCamilla Mazzoni, Lisa Argnani, Beatrice Casadei, et al.
Blood|November 2, 2006
Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experienceMaria Gabriella Mazzucconi, Paola Fazi, Sayla Bernasconi, et al.
The Journal of Pathology|August 12, 2009
Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray-based CGH analysisCaterina Marchiò, Maryou B Lambros, Patrizia Gugliotta, et al.
Human Pathology|July 26, 2015
Immunohistochemical and molecular profiling of histologically defined apocrine carcinomas of the breastSemir Vranic, Caterina Marchiò, Isabella Castellano, et al.
Pageof 47